EV Biologics, Inc. (YECO)

EV Biologics Revenue

In the year 2017, EV Biologics had annual revenue of $9.47M, down -0.34%. EV Biologics had revenue of $2.46M in the quarter ending June 30, 2017, a decrease of -78.05%. That makes EV Biologics the 37,609th largest company in the world by revenue and 4,941st in the United States.

• Revenue: 9.47M
• Revenue Growth: -70.48%
• P/S Ratio: 0.00
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.02K

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Yulong Concrete and Yulong Transport 5.93M 62.3%
• Yulong Bricks 3.08M 32.4%
• Yulong Renewable 496.83K 5.2%

Fiscal year ended Jun 30, 2017

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2017	9.47M	-32.45K	-0.34%
Jun 30, 2017	9.51M	-33.14M	-77.71%
Jun 30, 2016	42.64M	-3.59M	-7.76%
Jun 30, 2015	46.23M	1.77M	3.99%
Jun 30, 2014	44.46M	1.98M	4.65%

Data Source: S&P Global Market Intelligence Last updated: Nov 15, 2017

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error